Variant estrogen and progesterone receptor messages in human vascular smooth muscle

Circulation

Volumn 99, Issue 20, 1999, Pages 2688-2693

  Hodges, Yvonne K ^a   Richer, Jennifer K ^a   Horwitz, Kathryn B ^a   Horwitz, Lawrence D ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Coronary disease; Genes; Hormones; Muscle, smooth; Receptors

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; GESTAGEN; PROGESTERONE RECEPTOR; RNA; SEX HORMONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; HUMAN; HUMAN TISSUE; MALE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE;

EID: 0033602822     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.20.2688     Document Type: Article

References (32)

1. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991;20:47-63.
2. Karas RH, Patterson BL, Mendelsohn ME. Inhibition of vascular smooth muscle cell growth by estrogen. Circulation. 1994;89:1943-1950.
3. Chen S-J, Li H, Durand J, Oparil S, Chen Y-F. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation. 1996;93:577-584.
4. Dai-Do D, Espinosa E, Liu G, Rabelink TJ, Julmy F, Yang Z, Mahler R, Lüscher TF. 17β-Estradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from postmenopausal females and in males. Cardiovasc Res. 1996;32:980-985.
5. Kumar V, Green S, Stack G, Berry M, Jinn J, Chambon P. Functional domains of the human estrogen receptor. Cell. 1987;51:941-945.
6. Horwitz KB, Horwitz LD. Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids. J Clin Invest. 1982; 69:750-758.
7. King RJ. A discussion of the roles of oestrogen and progestin in human mammary carcinogenesis. J Steroid Biochem Mol Biol. 1991;39: 811-818.
8. Rider V, Carlone DL, Foster RT. Oestrogen and progesterone control basic fibroblast growth factor mRNA in the rat uterus. J Endocrinol. 1997;154:75-84.
9. Ordog T, Vertes Z, Vertes M. Role of endogenous opioids in progesterone antagonism on oestradiol-induced DNA synthesis in the rat uterus. J Steroid Biochem Mol Biol. 1993;45:455-457.
10. Bhakoo HS, Katzenellenbogen BS. Progesterone antagonism of estradiol-stimulated uterine "induced protein" synthesis. Mol Cell Endocrinol. 1977;8:105-120.
11. Morey AK, Pedram A, Razandi M, Prins BA, Hu R-M, Biesiada E, Levin ER. Estrogen and progesterone inhibit vascular smooth muscle proliferation. Endocrinology. 1997;138:3330-3339.
12. Lee W-S, Harder JA, Yoshizumi M, Lee M-E, Haber E. Progesterone inhibits arterial smooth muscle cell proliferation. Nat Med. 1997;3: 1005-1008.
13. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996;93:5925-5930.
14. Mosselman S, Polman J, Dijkema R. ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996;392:49-53.
15. Kastner P, Krust A, Turotte B, Stropp U, Tora L, Gronemeyer H, Chambon P. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 1990;9:1603-1614.
16. Horwitz KB, Alexander PS. In situ photolinked nuclear progesterone receptors of human breast cancer cells: subunit molecular weights after transformation and translocation. Endocrinology. 1983;113:2195-2201.
17. Fuqua SAW, Fitzgerald SD, Chamness GC, Tandon AK, McDonnell DP, Nawaz Z, O'Malley BW, McGuire WL. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res. 1991;51:105-109.
18. Leygue ER, Watson PH, Murphy LC. Estrogen receptor variants in normal human mammary tissue. J Natl Cancer Inst. 1996;88:284-290.
19. Koehorst SGA, Cox JJ, Donker GH, Lopes de Silva S, Burbach JPH, Thijssen JHH, Blankenstein MA. Functional analysis of an alternatively spliced estrogen receptor lacking exon 4 isolated from MCF-7 breast cancer cells and meningioma tissue. Mol Cell Endocrinol. 1994;101: 237-245.
20. Inoue S, Hoshino S, Miyoshi H, Akishita M, Hosoi T, Orimo H, Ouchi Y. Identification of a novel isoform of estrogen receptor, a potential inhibitor of estrogen action, in vascular smooth muscle cells. Biochem Biophys Res Commun. 1996;219:766-772.
21. Richer JK, Lange CA, Wierman AM, Brooks KM, Tung L, Takimoto GS, Horwitz KB. Progesterone receptor variants found in breast cells repress transcription by wild-type receptor. Breast Cancer Res Treat. 1998;48: 231-241.
22. Leygue E, Dotzlaw H, Watson PH, Murphy LC. Identification of novel progesterone receptor variant mRNAs in human breast tissue. Biochem Biophys Res Commun. 1996;228:63-68.
23. Wang Y, Miksicek RJ. Identification of a dominant negative form of the human estrogen receptor. Mol Endocrinol. 1991;5:1707-1715.
24. Fuqua SAW, Fitzgerald SD, Allred DC, Elledge RM, Nawaz Z, McDonnell DP, O'Malley BW, Greene GL, McGuire WL. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res. 1992;52:483-486.
25. Chu S, Fuller PJ. Identification of a splice variant of the rat estrogen receptor beta gene. Mol Cell Endocrinol. 1997;132:195-199.
26. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation. 1994;89: 1943-1950.
27. Williams JK, Honore EK, Washburn SA, Clarkson TB. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol. 1994;24:1757-1761.
28. Miyagawa K, Roch J, Stanczyk F, Hersmeyer K. Medroxyprogesterone interfered with ovarian steroid protection against coronary vasospasm. Nat Med. 1997;3:324-327.
29. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary artery disease in postmenopausal women: Heart and Estrogen/progestin Replacement Study (HERS) research group. JAMA. 1998;280:605-613.
30. Takimoto G, Hovland AR, Tasset DM, Melville MT, Tung L, Horwitz KB. Role of phosphorylation on DNA binding and transcriptional functions of human progesterone receptors. J Biol Chem. 1996;271: 13308-13316.
31. McDonnell DP, Goldman ME. RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism. J Biol Chem. 1994;269:11945-11949.
32. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR Jr, Lubahn DB, Donnell TF, Korach KS, Mendelsohn ME. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat Med. 1997; 3:545-548.